Regional homovanillic acid production in humans.

Peripheral plasma levels of homovanillic acid (HVA), the deaminated and o-methylated metabolite of dopamine, are often used as an indicator of central nervous system dopaminergic activity. Using percutaneously placed catheters, we studied the regional inputs into the plasma HVA pool in 60 healthy volunteers. Veno-arterial differences and organ plasma flows were used to quantify the relative amounts of HVA contributed by various sites into the peripheral circulation. Positive arterio-venous HVA gradients were found in the pulmonary, hepatosplanchnic, skeletal muscle and jugular vessels of the normal volunteers. No HVA increment was found in the coronary sinus. The renal circulation was determined to be the principal site of HVA clearance, extracting 27 nmol/min. The regional contributions of HVA were as follows: lungs 21 nmol/min, hepatosplanchnic organs 3 nmol/min, skeletal muscle 3 nmol/min and the brain 4 nmol/min. The pattern of regional HVA production contrasted with that of the deaminated dopamine metabolite, dihydroxyphenylacetic acid, for which the heart was the principal site of production identified. Sixteen patients with chronic congestive heart failure (CHF) and 6 patients with pure autonomic failure (PAF) were also studied to investigate possible effects of sympathetic nervous system overactivity and underactivity on peripheral HVA production and plasma HVA concentration. The resting arterial plasma HVA concentration in CHF was increased approximately 3-fold. Unexpectedly, this was attributable to reduced HVA plasma clearance, not increased HVA production. Total HVA production in PAF was diminished by 40%. PAF patients had normal resting arterial HVA levels, this being accounted for by a 57% fall in the renal plasma clearance of HVA. Acute sympathetic nervous system activation in response to bicycle riding was accompanied by a 34% increase in the arterial concentration of HVA. It can be concluded that HVA is produced at a number of sites throughout the body not renowned for their dopaminergic innervation. Regional HVA production is associated, in part, with the metabolism of precursor dopamine in sympathetic nerves and at a rate which appears to be influenced by sympathetic nervous activity. To obtain an accurate indication of central dopaminergic activity the confounding influences of HVA plasma clearance and peripheral HVA production must be excluded.

[1]  B. Brooks,et al.  Relationship between norepinephrine in blood and cerebrospinal fluid in the presence of a blood cerebrospinal fluid barrier for norepinephrine , 1977, Journal of neurochemistry.

[2]  W. Anderson,et al.  Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. , 1988, Hypertension.

[3]  R. Shipley,et al.  Tracer methods for in-vivo kinetics;: Theory and applications , 1972 .

[4]  J. Axelrod,et al.  Blood-Brain Barrier for Adrenaline , 1959, Science.

[5]  D. Goldstein,et al.  Plasma dihydroxyphenylglycol for estimation of noradrenaline neuronal re-uptake in the sympathetic nervous system in vivo. , 1989, Clinical science.

[6]  I. Kopin,et al.  Kinetics of homovanillic acid and determination of its production rate in the rhesus monkey. , 1979, Life sciences.

[7]  C. Bowden,et al.  Effects of debrisoquin on CSF and plasma HVA concentrations in man. , 1985, Life sciences.

[8]  J. Hsiao,et al.  Effects of renal clearance on plasma concentrations of homovanillic acid. Methodologic cautions. , 1989, Archives of general psychiatry.

[9]  J. Kelsoe,et al.  Plasma Homovanillic Acid as an Index of Central Dopaminergic Activity: Studies in Schizophrenic Patients , 1988, Annals of the New York Academy of Sciences.

[10]  C. Bowden,et al.  Dopamine metabolism and disposition in schizophrenic patients. Studies using debrisoquin. , 1988, Archives of general psychiatry.

[11]  J. Maas,et al.  A DIRECT METHOD FOR DETERMINING DOPAMINE SYNTHESIS AND OUTPUT OF DOPAMINE METABOLITES FROM BRAIN IN AWAKE ANIMALS , 1979, Journal of neurochemistry.

[12]  J. M. Doidge,et al.  Adrenergic and non-adrenergic inhibitory nerves in mammalian airways. , 1982, Journal of the autonomic nervous system.

[13]  D. Goldstein,et al.  Neuronal source of plasma dihydroxyphenylalanine. , 1987, The Journal of clinical endocrinology and metabolism.

[14]  C. Altar,et al.  Dopamine release in vivo from nigrostriatal, mesolimbic, and mesocortical neurons: utility of 3-methoxytyramine measurements. , 1988, Pharmacological reviews.

[15]  I. Meredith,et al.  Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. , 1990, Physiological reviews.

[16]  K. Davis,et al.  Control of exogenous factors affecting plasma homovanillic acid concentration , 1987, Psychiatry Research.

[17]  I. Kopin,et al.  Catecholamine metabolism: basic aspects and clinical significance. , 1985, Pharmacological reviews.

[18]  A. Quyyumi,et al.  Sympathetic Nervous Function in Human Heart as Assessed by Cardiac Spillovers of Dihydroxyphenylglycol and Norepinephrine , 1992, Circulation.

[19]  I. Kopin,et al.  Relationship between urinary excretion of homovanillic acid and norepinephrine metabolites in normal subjects and patients with orthostatic hypotension. , 1988, Life sciences.

[20]  P. Korner,et al.  Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. , 1986, Circulation.

[21]  I. Kopin,et al.  Kinetics of Homovanillie Acid and Determination of Its Production Rate in Humans , 1982, Journal of neurochemistry.

[22]  I. Kopin,et al.  Contribution of plasma homovanillic acid (HVA) to urine and cerebrospinal fluid HVA in the monkey and its pharmacokinetic disposition. , 1978, Life sciences.

[23]  R. Roth,et al.  3,4-Dihydroxyphenylacetic acid and homovanillic acid in rat plasma: possible indicators of central dopaminergic activity. , 1979, European journal of pharmacology.

[24]  J. Kleinman,et al.  Dopamine and its metabolites in human peripheral nerves: is there a widely distributed system of peripheral dopaminergic nerves? , 1981, Life sciences.

[25]  O. Hornykiewicz Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA). , 1973, British medical bulletin.

[26]  R. Wurtman,et al.  EFFECT OF SELECTIVE DESTRUCTION OF CENTRAL AND PERIPHERAL CATECHOLAMINE‐CONTAINING NEURONES WITH 6‐HYDROXYDOPAMINE ON CATECHOLAMINE EXCRETION IN THE RAT , 1974, British journal of pharmacology.

[27]  B. G. Wolthers,et al.  Injurious effect of EDTA contamination on colorimetry of serum iron. , 1985, Clinical chemistry.

[28]  I. Meredith,et al.  Increased plasma dihydroxyphenylalanine during sympathetic activation in humans is related to increased norepinephrine turnover. , 1991, The Journal of laboratory and clinical medicine.

[29]  G. Jennings,et al.  Direct determination of homovanillic acid release from the human brain, an indicator of central dopaminergic activity. , 1991, Life sciences.

[30]  A. Quyyumi,et al.  Regional extraction of circulating norepinephrine, DOPA, and dihydroxyphenylglycol in humans. , 1991, Journal of the autonomic nervous system.

[31]  S. Stahl,et al.  The dopamine hypothesis of schizophrenia: a review. , 1976, Schizophrenia bulletin.